Trade

with

Bio-Rad Laboratories Inc
(NYSE: BIO)
AdChoices
112.47
-0.16
-0.14%
After Hours :
112.47
0.00
0.00%

Open

112.49

Previous Close

112.63

Volume (Avg)

69.71k (67.66k)

Day's Range

111.93-113.54

52Wk Range

105.30-134.13

Market Cap.

3.25B

Dividend Rate ( Yield )

-

Beta

1.22

Shares Outstanding

23.78M

P/E Ratio (EPS)

53.19 (2.11)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 2.13B

    • Net Income

    • 77.79M

    • Market Cap.

    • 3.25B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 2.85

    • PEG (Price/Earnings Growth) Ratio

    • 1.91

    • Beta

    • 1.22

    • Forward P/E

    • 18.15

    • Price/Sales

    • 1.52

    • Price/Book Value

    • 1.44

    • Price/Cash flow

    • 11.59

      • EBITDA

      • 320.86M

      • Return on Capital %

      • 1.76

      • Return on Equity %

      • 2.84

      • Return on Assets %

      • 1.76

      • Book Value/Share

      • 77.94

      • Shares Outstanding

      • 23.78M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 2.20

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -52.50

          • -5.55

          • Net Income

            Q/Q (last year)

          • -8.60

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • 3.86

          • 47.82

          • Net Income

            5-Year Annual Average

          • -2.80

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 54.76

            • 42.70

            • Pre-Tax Margin

            • 4.76

            • 11.63

            • Net Profit Margin

            • 2.85

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 56.10

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 9.90

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • 7.60

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.19

              • 0.62

              • Current Ratio

              • 3.68

              • 1.23

              • Quick Ratio

              • 2.14

              • 0.76

              • Interest Coverage

              • 3.14

              • 5.98

              • Leverage Ratio

              • 1.54

              • 2.16

              • Book Value/Share

              • 77.94

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 53.19

                • 33.22

                • P/E Ratio 5-Year High

                • 63.47

                • 325.07

                • P/E Ratio 5-Year Low

                • 37.85

                • 154.73

                • Price/Sales Ratio

                • 1.52

                • 2.34

                • Price/Book Value

                • 1.44

                • 3.04

                • Price/Cash Flow Ratio

                • 11.59

                • 19.08

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 2.84

                    (9.80)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • 1.76

                    (5.20)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • 3.37

                    (4.70)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • 7.91k

                  • 17.17k

                  • Inventory Turnover

                  • 1.94

                  • 5.07

                  • Asset Turnover

                  • 0.62

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  169.46M
                  Operating Margin
                  7.95
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  11.59
                  Ownership

                  Institutional Ownership

                  71.02%

                  Top 10 Institutions

                  35.22%

                  Mutual Fund Ownership

                  36.21%

                  Float

                  82.82%

                  5% / Insider Ownership

                  24.03%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Eaton Vance Atlanta Capital SMID-Cap Fd

                  •  

                    1,158,858

                  • 3.31

                  • 4.01

                  • Champlain - Small Cap Equity

                  •  

                    429,385

                  • -2.01

                  • 1.49

                  • Ariel Fund

                  •  

                    416,083

                  • 21.17

                  • 1.44

                  • Transamerica Large Cap Value

                  •  

                    413,617

                  • 3.76

                  • 1.43

                  • Royce Special Equity Fund

                  •  

                    370,000

                  • -23.08

                  • 1.28

                  • Vanguard Small Cap Index

                  •  

                    351,175

                  • -0.09

                  • 1.22

                  • Vanguard Total Stock Mkt Idx

                  •  

                    337,333

                  • 0.12

                  • 1.17

                  • iShares Core S&P Mid-Cap (AU)

                  •  

                    280,281

                  • 0.13

                  • 0.96

                  • Champlain Mid Cap Fund

                  •  

                    230,070

                  • 115.02

                  • 0.80

                  • American Century Mid Cap Value Fund

                  •  

                    221,169

                  • 10.48

                  • 0.77

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Eaton Vance Management

                  •  

                    1,865,472

                  • +16.14%

                  • 6.48

                  • Atlanta Capital Management Company,LLC

                  •  

                    1,837,954

                  • +2.09%

                  • 6.37

                  • Vanguard Group, Inc.

                  •  

                    1,171,820

                  • +2.16%

                  • 4.06

                  • Ariel Investments, LLC

                  •  

                    983,452

                  • -4.03%

                  • 3.41

                  • Levin Capital Strategies, L.P.

                  •  

                    953,801

                  • -0.22%

                  • 3.30

                  • Champlain Investment Partners, LLC

                  •  

                    826,155

                  • +3.29%

                  • 2.86

                  • Royce & Associates, LLC

                  •  

                    812,845

                  • -6.88%

                  • 2.82

                  • BlackRock Fund Advisors

                  •  

                    621,125

                  • +8.79%

                  • 2.15

                  • State Street Corp

                  •  

                    566,095

                  • +1.46%

                  • 1.96

                  • NWQ Investment Management Co LLC

                  •  

                    523,806

                  • +20.72%

                  • 1.81

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Slow Growth

                  Style

                  Small Core

                  Bio-Rad Laboratories Inc was founded in 1952 and incorporated in 1957. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to s...moreeparate complex chemical and biological materials and to identify, analyze and purify their components. It operates in two industry segments designated as Life Science and Clinical Diagnostics. Both segments operate worldwide. Life science is the study of the characteristics, behavior, and structure of living organisms and their component systems. Life Science segment is at the forefront of discovery, creating advanced tools to answer complex biological questions. The Company is engaged in developing, manufacturing and marketing a range of more than 5,000 reagents, appar...moreatus and laboratory instruments that serve a global customer base. Many of its products are used in established research techniques, biopharmaceutical production processes and food testing regimes. These techniques are typically used to separate, purify and identify biological materials such as proteins, nucleic acids and bacteria within a laboratory or production setting. Its main life science customers include universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers and food testing laboratories. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. Its products currently address specific niches within the in vitro diagnostics (IVD) test market. It supplies more than 3,000 different products that cover more than 300 clinical diagnostic tests to the IVD test market. IVD tests are conducted outside the human body and are used to identify and measure substances in a patient’s tissue, blood or urine. Its products consist of reagents, instruments and software, typically provided to its customers as an integrated package to allow them to generate reproducible test results. Its main clinical diagnostic customers include hospital laboratories, reference laboratories, transfusion laboratories and physician office laboratories. The Company owns numerous U.S. and international patents and patent licenses. Each of the Company's segments maintains a sales force to sell its products on a direct basis. Major competitors in the clinical diagnostic segment include Roche, Abbott Laboratories (Diagnostic Division), Siemens Medical Diagnostics Solutions (formerly Dade-Behring, Diagnostics Products Corporation, and Bayer Diagnostics), Beckman Coulter, Becton-Dickinson, bioMérieux, Johnson & Johnson (Ortho Clinical Diagnostics), Thermo Fisher, Tosoh, Immucor, Cepheid, and DiaSorin. The Company’s operations are subject to federal, state, local and foreign environmental laws and regulations that govern such activities as transportation of goods, emissions to air and discharges to water, as well as handling and disposal practices for solid, hazardous and medical wastes.lessless

                  Key People

                  Norman Schwartz

                  CEO/Chairman of the Board/Director/President

                  Christine A. Tsingos

                  CFO/Executive VP

                  Giovanni Magni

                  Executive VP, Divisional

                  Ronald W. Hutton

                  Executive VP/Treasurer

                  Shawn Marie Soderberg

                  Executive VP/General Counsel/Secretary

                  • Bio-Rad Laboratories Inc

                  • 1000 Alfred Nobel Drive

                  • Hercules, CA 94547

                  • USA.Map

                  • Phone: +1 510 724-7000

                  • Fax: +1 510 741-5817

                  • bio-rad.com

                  Incorporated

                  1957

                  Employees

                  7,750

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: